Published in Proc Natl Acad Sci U S A on March 01, 1977
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A (1978) 4.59
Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev (1998) 4.59
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Poliovirus-specific primer-dependent RNA polymerase able to copy poly(A). Proc Natl Acad Sci U S A (1977) 3.69
Identification of poliovirus polypeptide P63 as a soluble RNA-dependent RNA polymerase. J Virol (1980) 3.26
Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol (1986) 3.24
Poliovirus polyuridylic acid polymerase and RNA replicase have the same viral polypeptide. J Virol (1979) 3.12
Strand breakage by the DNA untwisting enzyme results in covalent attachment of the enzyme to DNA. Proc Natl Acad Sci U S A (1977) 3.04
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res (1984) 3.00
Poliovirus replication proteins: RNA sequence encoding P3-1b and the sites of proteolytic processing. Proc Natl Acad Sci U S A (1981) 2.91
Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies. J Virol (1991) 2.75
Specific Sindbis virus-coded function for minus-strand RNA synthesis. J Virol (1981) 2.69
Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA. J Virol (1995) 2.67
5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis. EMBO J (2001) 2.67
Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci U S A (1989) 2.55
Identification of a protein linked to nascent poliovirus RNA and to the polyuridylic acid of negative-strand RNA. J Virol (1978) 2.54
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Role of a viral membrane polypeptide in strand-specific initiation of poliovirus RNA synthesis. J Virol (1991) 2.44
Protein p3 is linked to the DNA of phage phi 29 through a phosphoester bond between serine and 5'-dAMP. Proc Natl Acad Sci U S A (1980) 2.42
Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA. J Virol (1981) 2.40
Coupled translation and replication of poliovirus RNA in vitro: synthesis of functional 3D polymerase and infectious virus. J Virol (1993) 2.38
Gamma-monomethyl phosphate: a cap structure in spliceosomal U6 small nuclear RNA. Proc Natl Acad Sci U S A (1989) 2.34
Isolation of a soluble and template-dependent poliovirus RNA polymerase that copies virion RNA in vitro. J Virol (1979) 2.21
Bacteriophage phi29 terminal protein: its association with the 5' termini of the phi29 genome. J Virol (1978) 2.20
Genome-linked protein VPg of poliovirus is present as free VPg and VPg-pUpU in poliovirus-infected cells. Proc Natl Acad Sci U S A (1983) 2.20
Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation. J Virol (2000) 2.18
Poliovirus RNA-dependent RNA polymerase and host cell protein synthesize product RNA twice the size of poliovirion RNA in vitro. J Virol (1985) 2.11
Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J Virol (1997) 2.04
Purification and properties of poliovirus RNA polymerase expressed in Escherichia coli. J Virol (1989) 2.00
Genome-linked protein associated with the 5' termini of bacteriophage phi29 DNA. J Virol (1978) 1.92
Covalent association of protein with replicative form DNA of parvovirus H-1. Proc Natl Acad Sci U S A (1979) 1.92
Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J Virol (1992) 1.88
Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region. J Virol (1988) 1.85
Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus. J Virol (1991) 1.84
Purification of a terminal uridylyltransferase that acts as host factor in the in vitro poliovirus replicase reaction. Proc Natl Acad Sci U S A (1986) 1.80
A protein linked to the 5' termini of both RNA components of the cowpea mosaic virus genome. Nucleic Acids Res (1978) 1.79
In vitro synthesis of infectious poliovirus RNA. Proc Natl Acad Sci U S A (1985) 1.78
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. Proc Natl Acad Sci U S A (1986) 1.72
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70
Characterization of poliovirus clones containing lethal and nonlethal mutations in the genome-linked protein VPg. J Virol (1990) 1.69
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
p53 is covalently linked to 5.8S rRNA. Mol Cell Biol (1992) 1.65
Mechanism of poliovirus inactivation by ammonia. J Virol (1978) 1.64
Sequence of 1060 3'-terminal nucleotides of poliovirus RNA as determined by a modification of the dideoxynucleotide method. Proc Natl Acad Sci U S A (1980) 1.61
Construction of a "mutagenesis cartridge" for poliovirus genome-linked viral protein: isolation and characterization of viable and nonviable mutants. Proc Natl Acad Sci U S A (1988) 1.61
Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro. J Virol (1986) 1.60
Encephalomyocarditis virus RNA. III. Presence of a genome-associated protein. J Virol (1978) 1.59
The tumor suppressor p53 is bound to RNA by a stable covalent linkage. Mol Cell Biol (1991) 1.56
RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol. J Virol (1993) 1.51
Heterogeneity of the genome-linked protein of foot-and-mouth disease virus. J Virol (1980) 1.50
ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein. J Virol (1984) 1.47
Poliovirus RNA-dependent RNA polymerase synthesizes full-length copies of poliovirion RNA, cellular mRNA, and several plant virus RNAs in vitro. J Virol (1982) 1.46
Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J Virol (1989) 1.46
Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14. J Virol (2002) 1.40
Capsid protein precursor is one of two initiated products of translation of poliovirus RNA in vitro. J Virol (1979) 1.37
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol Ther (2009) 1.37
Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol. J Virol (1995) 1.37
Oligonucleotide mapping studies of standard and defective Sindbis virus RNA. J Virol (1979) 1.36
Antibodies Against the Genome-Linked Protein VPg of Cowpea Mosaic Virus Recognize a 60,000-Dalton Precursor Polypeptide. J Virol (1982) 1.34
Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region. J Virol (1992) 1.34
Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J Virol (1986) 1.29
Oligonucleotide mapping of non-radioactive virus and messenger RNAs. Nucleic Acids Res (1977) 1.29
Host factor-induced template modification during synthesis of poliovirus RNA in vitro. J Virol (1987) 1.29
Comparison of initiation rates of encephalomyocarditis virus and host protein synthesis in infected cells. J Virol (1978) 1.29
Identification and characterization of a protein covalently bound to DNA of minute virus of mice. J Virol (1986) 1.26
Replication of poliovirus RNA containing two VPg coding sequences leads to a specific deletion event. J Virol (1993) 1.24
Identification of specific fragments containing the 5' end of poliovirus RNA after ribonuclease III digestion. Nucleic Acids Res (1978) 1.23
Sequence of picornavirus RNAs containing a radioiodinated 5'-linked peptide reveals a conserved 5' sequence. Proc Natl Acad Sci U S A (1980) 1.22
Terminal proteins and short inverted terminal repeats of the small Bacillus bacteriophage genomes. Proc Natl Acad Sci U S A (1981) 1.22
Adenovirus terminal protein protects single stranded DNA from digestion by a cellular exonuclease. Nucleic Acids Res (1980) 1.20
The intervening sequence excised from the ribosomal RNA precursor of Tetrahymena contains a 5-terminal guanosine residue not encoded by the DNA. Nucleic Acids Res (1982) 1.18
Orientation of the cleavage map of the 200-kilodalton polypeptide encoded by the bottom-component RNA of cowpea mosaic virus. J Virol (1983) 1.17
Structure and function analysis of the poliovirus cis-acting replication element (CRE). RNA (2003) 1.17
Identification of a protein bound to the termini of bacteriophage PRD1 DNA. J Virol (1983) 1.16
Cowpea mosaic virus VPg: sequencing of radiochemically modified protein allows mapping of the gene on B RNA. EMBO J (1984) 1.16
Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence. J Virol (2005) 1.15
Anti-VPg antibody precipitation of product RNA synthesized in vitro by the poliovirus polymerase and host factor is mediated by VPg on the poliovirion RNA template. J Virol (1986) 1.15
An RNA element at the 5'-end of the poliovirus genome functions as a general promoter for RNA synthesis. PLoS Pathog (2010) 1.14
Structure-infectivity analysis of the human rhinovirus genomic RNA 3' non-coding region. Nucleic Acids Res (1996) 1.13
The nucleotide sequence at the 5' end of foot and mouth disease virus RNA. Nucleic Acids Res (1979) 1.13
Measurement of poliovirus RNA polymerase binding to poliovirion and nonviral RNAs using a filter-binding assay. Nucleic Acids Res (1988) 1.11
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10
Filter-binding assay for covalent DNA-protein complexes: adenovirus DNA-terminal protein complex. Proc Natl Acad Sci U S A (1978) 1.09
The structure of poliovirus replicative form. Nucleic Acids Res (1980) 1.07
Terminal 7-methyl-guanosine cap structure on the normally uncapped 5' noncoding region of poliovirus mRNA inhibits its translation in mammalian cells. J Virol (1991) 1.07
An electron microscope study of the proteins attached to polio virus RNA and its replicative form (RF). Nucleic Acids Res (1978) 1.06
In Vitro Replication of Cowpea Mosaic Virus RNA III. Template Recognition by Cowpea Mosaic Virus RNA Replicase. J Virol (1979) 1.06
Heterogeneity of the 3' end of minus-strand RNA in the poliovirus replicative form. J Virol (1980) 1.04
Intramolecular and intermolecular uridylylation by poliovirus RNA-dependent RNA polymerase. J Virol (2006) 1.03
Sequence homology adjacent to the 3' terminal poly(A) of cowpea mosaic virus RNAs. Nucleic Acids Res (1979) 1.02
Transfection of Escherichia coli spheroplasts with a bacteriophage Mu DNA-protein complex. J Virol (1982) 1.02
Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity. Virology (2009) 1.01
The structure of the covalent linkage between proteins and RNA in encephalomyocarditis virus. Nucleic Acids Res (1980) 1.01
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78
Molecular weight of poliovirus ribonucleic acid. J Virol (1969) 5.16
Polyadenylic acid on poliovirus RNA. II. poly(A) on intracellular RNAs. J Virol (1975) 3.65
Complete translation of poliovirus RNA in a eukaryotic cell-free system. Proc Natl Acad Sci U S A (1975) 3.51
Structural difference between the 5' termini of viral and cellular mRNA in poliovirus-infected cells: possible basis for the inhibition of host protein synthesis. J Virol (1976) 3.46
Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem (1975) 3.44
Requirement of 3'-terminal poly(adenylic acid) for the infectivity of poliovirus RNA. Proc Natl Acad Sci U S A (1974) 2.89
Nucleotide sequence complexities, molecular weights, and poly(A) content of the vesicular stomatitis virus mRNA species. J Virol (1975) 2.85
Translation in vitro of vesicular stomatitis virus mRNA lacking 5'-terminal 7-methylguanosine. Nature (1976) 2.81
5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73
Ribonuclease preparation for the base analysis of polyribonucleotides. Anal Biochem (1966) 2.11
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 34.17
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J (1991) 23.69
Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08
RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (1970) 19.38
An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (1987) 19.23
The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol (1999) 17.82
I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (1988) 16.40
Immunoglobulin gene transcription is activated by downstream sequence elements. Cell (1983) 15.53
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (1986) 14.34
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol (1981) 13.11
The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell (1997) 12.87
NF-kappa B: ten years after. Cell (1996) 12.80
Cloned poliovirus complementary DNA is infectious in mammalian cells. Science (1981) 12.50
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A (1970) 11.83
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell (1988) 11.62
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell (1989) 11.19
The "initiator" as a transcription control element. Cell (1989) 11.13
The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol Cell (2000) 10.92
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science (1990) 10.59
Polypeptide cleavages in the formation of poliovirus proteins. Proc Natl Acad Sci U S A (1968) 10.43
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
The V(D)J recombination activating gene, RAG-1. Cell (1989) 9.79
Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region. Cell (1981) 9.54
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol (1989) 9.37
RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science (1990) 9.33
Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature (1990) 9.31
Further evidence on the formation of poliovirus proteins. J Mol Biol (1970) 9.29
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell (1990) 9.24
A detailed model of reverse transcription and tests of crucial aspects. Cell (1979) 8.93
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc Natl Acad Sci U S A (1982) 8.53
Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell (1985) 8.16
Identification of a ten-amino acid proline-rich SH3 binding site. Science (1993) 8.05
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (1987) 7.63
Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell (1995) 7.55
ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev (2000) 7.28
Defective viral particles and viral disease processes. Nature (1970) 7.24
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature (1998) 6.94
Heterochronic mutants of the nematode Caenorhabditis elegans. Science (1984) 6.85
A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell (1990) 6.85
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood (1998) 6.81
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity (1999) 6.80
5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine. Nature (1980) 6.76
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci U S A (1980) 6.73
Gene conversion: some implications for immunoglobulin genes. Cell (1981) 6.70
Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J (1984) 6.67
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell (1991) 6.63
Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J Mol Biol (1968) 6.58
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol (1990) 6.57
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell (1991) 6.48
Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. Proc Natl Acad Sci U S A (1978) 6.38
Modular binding domains in signal transduction proteins. Cell (1995) 6.34
Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev (1996) 6.32
Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell (1981) 6.31
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J (1993) 6.29
The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev (1988) 6.23
RNA metabolism of murine leukemia virus: detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA. J Mol Biol (1973) 6.19
RNA-directed DNA synthesis and RNA tumor viruses. Adv Virus Res (1972) 6.11
Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus. Cell (1979) 6.03
Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules. Virology (1970) 5.99
Aspects of the synthesis of poliovirus RNA and the formation of virus particles. Virology (1966) 5.85
In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus. Cell (1979) 5.78
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature (1984) 5.75
Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles. J Virol (1969) 5.73
High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell (1978) 5.72
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell (1980) 5.68
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. Genes Dev (1989) 5.61
Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3' ends. Cell (1980) 5.59
Primer requirement and template specificity of the DNA polymerase of RNA tumor viruses. Proc Natl Acad Sci U S A (1971) 5.55
The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell (1989) 5.50
A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell (1990) 5.39
The mechanism of RNA recombination in poliovirus. Cell (1986) 5.35
Translation of MuLV and MSV RNAs in nuclease-treated reticulocyte extracts: enhancement of the gag-pol polypeptide with yeast suppressor tRNA. Cell (1978) 5.31
Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J Virol (1985) 5.21
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J Exp Med (1976) 5.13
Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol Cell Biol (1985) 4.94
An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell (1991) 4.80
Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc Natl Acad Sci U S A (1990) 4.79
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med (1996) 4.79
Ordered transcription of RNA tumor virus genomes. J Mol Biol (1976) 4.78
Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell (1990) 4.78
The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc Natl Acad Sci U S A (1991) 4.66
Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A (1978) 4.59
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (1990) 4.59
Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science (1992) 4.57
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature (1992) 4.46
Tumor viruses: 1974. Cold Spring Harb Symp Quant Biol (1975) 4.44
Retracted Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity (1999) 4.42
Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol (1991) 4.42
HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell (1989) 4.40
Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell (1997) 4.39